Financials
- Market Capitalization 1.03 B
- Employee 829
- Founded 2006
- CEO N/A
- Website www.pacira.com
- Headquarter Delaware, United States
- FIGI BBG0018FQNS6
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2235 | HROW Harrow, Inc. - Common Stock | 37.27 USD | -3.30% | -7.54% | -3.65% | -4.44% | 1.40 B USD | ||
| 2318 | CRON Cronos Group Inc. - Common Share | 3.38 USD | -0.29% | +2.11% | +17.36% | +33.07% | 1.25 B USD | ||
| 2495 | AMPH Amphastar Pharmaceuticals, Inc. - Common Stock | 22.01 USD | +0.59% | +1.90% | +8.37% | -9.72% | 936.26 M USD | ||
| 2592 | COLL Collegium Pharmaceutical, Inc. - Common Stock | 25.35 USD | -4.12% | -6.39% | -29.03% | -27.86% | 825.28 M USD |
Frequently asked questions about Pacira BioSciences, Inc. Common Stock
What is the Pacira BioSciences, Inc. Common Stock stock price today?
The current price of Pacira BioSciences, Inc. Common Stock (PCRX) is 25.76. Over the past 24 hours, the stock has changed by -0.27%. Follow the PCRX chart for real-time price dynamics.
What is the stock ticker of Pacira BioSciences, Inc. Common Stock?
Pacira BioSciences, Inc. Common Stock trades under the ticker PCRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pacira BioSciences, Inc. Common Stock stock going up?
PCRX has changed by +4.72% over the last week, -2.83% over the last month, and +18.00% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Pacira BioSciences, Inc. Common Stock?
Pacira BioSciences, Inc. Common Stock currently has a market capitalization of 1.03 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Pacira BioSciences, Inc. Common Stock earnings last quarter?
Last quarter, Pacira BioSciences, Inc. Common Stock reported earnings of 0.12 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Pacira BioSciences, Inc. Common Stock revenue for the last quarter?
Pacira BioSciences, Inc. Common Stock reported quarterly revenue of 192.4 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Pacira BioSciences, Inc. Common Stock net income for the last quarter?
Pacira BioSciences, Inc. Common Stock reported net income of 4.65 M for the last quarter. The previous quarter showed 2.92 M, which means net income changed by +59.57%.
How many employees does Pacira BioSciences, Inc. Common Stock have?
As of the latest available data, Pacira BioSciences, Inc. Common Stock has 829 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pacira BioSciences, Inc. Common Stock EBITDA?
Pacira BioSciences, Inc. Common Stock EBITDA is 25.56 M, and its EBITDA margin is 13.29%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pacira BioSciences, Inc. Common Stock stock?
You can buy Pacira BioSciences, Inc. Common Stock (PCRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pacira BioSciences, Inc. Common Stock stock?
Investing in Pacira BioSciences, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the PCRX chart and related analysis on metatrader.com as part of your research.